Abiopharma

Dr. Reddy’s Laboratories Ltd (RDY) Files Form 6-K

📋 Levy Raphi (Officer) plans to sell 20K shares of Alpha Tau Medical Ltd. (at $5.90 each, total $118K) Filed: Jan 08, 2026 | ID: 000007

New Form EFFECT - Sharps Technology Inc. Filed: 2026-01-08 AccNo: 9999999995-26-000109 Size: 1 KB

New Form EFFECT - DarioHealth Corp. Filed: 2026-01-08 AccNo: 9999999995-26-000108 Size: 1 KB

New Form EFFECT - Mersana Therapeutics, Inc. Filed: 2026-01-08 AccNo: 9999999995-26-000105 Size: 1 KB

Linde Announces Fourth Quarter 2025 Earnings and Conference Call Schedule

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis

RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026

Insulet - Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Grey symbol attribute type Security_Name was changed. Previous value: INDEPENDENCE PWR HLDGS A. New value: NERVGEN PHARMA CORP.

Q & M Dental Group (Singapore) Limited - Announcement

Labeling changes approved for EPIC PHARMA LLC. Active ingredient: PROTRIPTYLINE HYDROCHLORIDE. Decision date: 01/07/2026

Manufacturing process update for INNOGENIX. Submission: SUPPL-3. Decision date: 01/07/2026

Labeling changes approved for AUROBINDO PHARMA LTD. Active ingredient: ACETAZOLAMIDE. Decision date: 01/08/2026